164 related articles for article (PubMed ID: 21910160)
21. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.
Devlin L; Okletey J; Perkins G; Bowen JR; Nakos K; Montagna C; Spiliotis ET
Proteomics; 2021 Oct; 21(19):e2100155. PubMed ID: 34409731
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
23. Aneuploidy and tumorigenesis.
Fang X; Zhang P
Semin Cell Dev Biol; 2011 Aug; 22(6):595-601. PubMed ID: 21392584
[TBL] [Abstract][Full Text] [Related]
24. Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis.
Estey MP; Di Ciano-Oliveira C; Froese CD; Fung KYY; Steels JD; Litchfield DW; Trimble WS
J Biol Chem; 2013 Oct; 288(42):30075-30086. PubMed ID: 23990466
[TBL] [Abstract][Full Text] [Related]
25. Septin roles in tumorigenesis.
Connolly D; Abdesselam I; Verdier-Pinard P; Montagna C
Biol Chem; 2011 Aug; 392(8-9):725-38. PubMed ID: 21740328
[TBL] [Abstract][Full Text] [Related]
26. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis.
Li JJ; Li SA
Pharmacol Ther; 2006 Sep; 111(3):974-84. PubMed ID: 16603252
[TBL] [Abstract][Full Text] [Related]
27. Regulation of microtubule plus end dynamics by septin 9.
Nakos K; Rosenberg M; Spiliotis ET
Cytoskeleton (Hoboken); 2019 Jan; 76(1):83-91. PubMed ID: 30144301
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
Lingle WL; Lukasiewicz K; Salisbury JL
Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.
Peterson EA; Kalikin LM; Steels JD; Estey MP; Trimble WS; Petty EM
Mamm Genome; 2007 Nov; 18(11):796-807. PubMed ID: 17922164
[TBL] [Abstract][Full Text] [Related]
30. An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry.
Hecht M; Rösler R; Wiese S; Johnsson N; Gronemeyer T
G3 (Bethesda); 2019 Jun; 9(6):1869-1880. PubMed ID: 30975701
[TBL] [Abstract][Full Text] [Related]
31. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis.
Scott M; McCluggage WG; Hillan KJ; Hall PA; Russell SE
Int J Cancer; 2006 Mar; 118(5):1325-9. PubMed ID: 16161048
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.
Gonzalez ME; Makarova O; Peterson EA; Privette LM; Petty EM
Cell Signal; 2009 Apr; 21(4):477-87. PubMed ID: 19071215
[TBL] [Abstract][Full Text] [Related]
33. Septin-microtubule association via a motif unique to isoform 1 of septin 9 tunes stress fibers.
Kuzmić M; Castro Linares G; Leischner Fialová J; Iv F; Salaün D; Llewellyn A; Gomes M; Belhabib M; Liu Y; Asano K; Rodrigues M; Isnardon D; Tachibana T; Koenderink GH; Badache A; Mavrakis M; Verdier-Pinard P
J Cell Sci; 2022 Jan; 135(1):. PubMed ID: 34854883
[TBL] [Abstract][Full Text] [Related]
34. Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms.
Iv F; Martins CS; Castro-Linares G; Taveneau C; Barbier P; Verdier-Pinard P; Camoin L; Audebert S; Tsai FC; Ramond L; Llewellyn A; Belhabib M; Nakazawa K; Di Cicco A; Vincentelli R; Wenger J; Cabantous S; Koenderink GH; Bertin A; Mavrakis M
J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34350965
[TBL] [Abstract][Full Text] [Related]
35. Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed.
Stanbery L; Petty EM
Breast Cancer Res; 2012 Jan; 14(1):101. PubMed ID: 22236777
[TBL] [Abstract][Full Text] [Related]
36. Centrosome amplification, chromosome instability and cancer development.
Fukasawa K
Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
[TBL] [Abstract][Full Text] [Related]
37. Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation.
Shekhar MP; Lyakhovich A; Visscher DW; Heng H; Kondrat N
Cancer Res; 2002 Apr; 62(7):2115-24. PubMed ID: 11929833
[TBL] [Abstract][Full Text] [Related]
38. Transient endoreplication down-regulates the kinesin-14 HSET and contributes to genomic instability.
Chen S; Stout JR; Dharmaiah S; Yde S; Calvi BR; Walczak CE
Mol Biol Cell; 2016 Oct; 27(19):2911-23. PubMed ID: 27489338
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the role of the tumor marker Nup88 in mitosis.
Hashizume C; Nakano H; Yoshida K; Wong RW
Mol Cancer; 2010 May; 9():119. PubMed ID: 20497554
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of lumican enhanced mitotic defects and aneuploidy in lung cancer cells.
Yang CT; Hsu PC; Chow SE
Cell Cycle; 2020 Jan; 19(1):97-108. PubMed ID: 31760859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
